| PharmaSUG CN |
2026 |
Safety Estimands and Analysis Dataset Design: Advancing Safety Evaluation in Clinical Trials |
Kun Ren, Zeyu Guang |
source |
11 |
| PharmaSUG |
2026 |
Algorithms to align the distribution of follow-up across independently collected cohorts when comparing time to event endpoints using conventional Kaplan Meier and Cox regression methods. |
Shankar Srinivasan, Yvonne Buttkewitz, Regina Uttenreuther, Baldeep Chani Talwar, Manjari Dissanayake |
source |
12 |
| PharmaSUG |
2026 |
Construction and Evaluation of External Controls Using Propensity Score Methods |
Bala Niharika Pillalamarri, Yayu Li, Hongbing Jin |
source |
14 |
| PharmaSUG |
2026 |
Following Your Footsteps: Maintaining Traceability in ADaM Datasets [presentation] |
Nancy Brucken, Karl Miller |
source |
59 |
| PharmaSUG |
2026 |
Oncology Solid Tumor Subcutaneous vs Intravenous Late-stage Study Analysis |
Sumanjali Mangalarapu, Chuqing Chen, Anilkumar Anksapur |
source |
11 |
| PharmaSUG |
2026 |
Operationalizing Real World Data for External Control Arms: An End to End Framework for Rare Disease and Oncology Trials |
Anbu Damodaran |
source |
7 |
| PHUSE US |
2026 |
Closing the Gap: Identifying Missing Tumour Assessments in Oncology Studies |
Ke Xiao |
source presentation source |
8 |
| PHUSE US |
2026 |
Demystifying TMLE: A Practical Approach for Clinical Data Scientists |
Joshua Enxing |
source presentation source |
12 |
| PHUSE US |
2026 |
Deriving Phantom Records in BDS Datasets To Support the FDA's Standard Safety Figures for Missing Data Analysis |
Guowei Wu, Ruchitbhai Patel |
source presentation source |
6 |
| PHUSE US |
2026 |
Framework for Incorporating Estimands within the Statistical Analysis Plan |
Inderjeet Arora |
source presentation source |
9 |
| PHUSE US |
2026 |
From Data Cutoffs to Decision-Making: Programming Futility Analysis in Oncology Clinical Trials |
Mani Mudumba |
source presentation source |
6 |
| PHUSE US |
2026 |
Group, Collapse, Repeat: A Dynamic SAS Macro for Stratification Pooling in Oncology Efficacy Analysis |
Venkatesh Burla |
source presentation source |
9 |
| PHUSE US |
2026 |
Handle with Care: Study-Specific Assessment of R Package Risk |
Shannon Grant |
source presentation source |
9 |
| PHUSE US |
2026 |
Implementing AI in Authoring Plain Language Summaries: Insights from a Live Project Experience [presentation] |
Vidhi Vashisht |
source |
18 |
| PHUSE US |
2026 |
Is There Really Any Benefit to Stratified Randomisation in Practice? |
Pavankumar Bhagat |
source presentation source |
9 |
| PHUSE US |
2026 |
Practical Survival Analysis Techniques for Clinical Trials Using SAS |
Xue Ding, Tianchen Xu |
source presentation source |
10 |
| PHUSE APAC |
2026 |
External Comparator Studies in the Era of Real-World Data |
Vishal Goriya, Anshul Sinha, Gerd Rippin |
source presentation source |
5 |
| PHUSE APAC |
2026 |
Illustrating treatment switching using Rank preserving structural failure time model in Oncology study |
Swarupa Changan |
source presentation source |
11 |
| PHUSE APAC |
2026 |
Leveraging Real-World Evidence (RWE) in Clinical Trial Design: Statistical Challenges and Opportunities |
Muhammed Farzan K |
source presentation source |
6 |
| PHUSE APAC |
2026 |
Targeted Maximum Likelihood Estimation: A Unified Approach for Confounding and Selection Bias |
Mahjoob O. Majeed, Noel S. John |
source presentation source |
6 |
| PHUSE EU |
2025 |
Blinded & Coordinated: Aligning People and Processes To Prevent Unblinding |
Monika Bajek, Dubravka Georgijevic |
source presentation source |
6 |
| PHUSE EU |
2025 |
Inverse Probability Weighting in Multiple Groups: Balancing Baseline Characteristics and Improving Precision of Average Treatment Effect Estimation |
Dimitris Karletsos |
source presentation source |
11 |
| PHUSE EU |
2025 |
Is There Really Any Benefit to Stratified Randomisation Compared to Simple Randomisation with Covariate Adjustment? |
Pavankumar Bhagat |
source presentation source |
9 |
| PHUSE EU |
2025 |
Leveraging LLM for R Shiny App Code Development: A Case Study with Event Prediction [presentation] |
Yirong Cao |
source |
15 |
| PHUSE EU |
2025 |
Navigating Experimental Arms in Subtype Studies: Strategies for Precision and Clarity |
Narek Torosyan, Edgar Sargsyan |
source presentation source |
4 |
| PHUSE EU |
2025 |
Poster PP11 |
Pragmatism Meets Precision, Andrea Parodi |
source poster source |
4 |
| SESUG |
2025 |
Preserving the Blind: Cross-Functional Solutions During Study Design Evolution from Blinded Parent to Open-Label Extension |
Tanmay Khole |
|
5 |
| SESUG |
2025 |
Statistical Programmer's role in Bioresearch Monitoring (BIMO) package creation |
Sampath Madanu |
|
25 |
| WUSS |
2025 |
PFS2, did you hear about it too? - Understanding the derivation of Progression Free Survival on next-line therapy (PFS2). |
Yeshashwini Chenna, Lupetu Ntambwe |
source |
11 |
| PharmaSUG |
2025 |
Avoiding the Ouch: Mastering Time to Pain Progression Analysis |
Kavitha Boinapally, Sai Krishna Pavan Nakirikanti, Hank Dennis, Yang Wang |
source |
9 |
| PharmaSUG |
2025 |
Breaking Barriers in Clinical Trials: Insights into Platform Designs |
Chetankumar Patel |
source |
11 |
| PharmaSUG |
2025 |
Efficacy Endpoints Related to CNS in Oncology Studies within ADaM |
Lihui Deng, Kylie Fan |
source |
6 |
| PharmaSUG |
2025 |
Implementation of the inverse probability of censoring weighting (IPCW) Model in Oncology Trials |
Mei Huang, Shibani Harite, Haijun Ma, Linsong (Athena) Zhang |
source |
17 |
| PharmaSUG |
2025 |
Roadmap to Efficacy Analysis for Early Phase Oncology studies |
Dhruv Bansal, Christiana Hawn, Chris Kelly |
source |
23 |
| PHUSE US |
2025 |
How Unique is it for the Subject Identifier in a Study To Have Multiple Screenings and Enrolments? |
Anahita Vyas, Rama Kudaravalli |
source presentation source |
8 |
| PHUSE US |
2025 |
The Ultimate Randomisation App |
Chen Li, Ivo Marek |
source presentation source |
9 |
| PHUSE EU |
2024 |
Strategies to Improve Understanding of Estimands and Analysis Section of Statistical Analysis Plan |
Inderjeet Arora |
source presentation source |
8 |
| SESUG |
2024 |
Applying Different Data Cutoff Dates for the Analysis of a Study Milestone |
Guowei Zhao, Hong Qi |
source |
7 |
| SESUG |
2024 |
Using PROC PSMATCH for Assembling Parallel Test Forms |
Tsung-Hsun Tsai, Yung-Chen Hsu |
source |
11 |
| PharmaSUG |
2024 |
ADaM Design for Prostate Cancer Efficacy Endpoints Based on PCWG3 |
Lihui Deng, Kylie Fan, Jia Li |
source |
10 |
| PharmaSUG |
2024 |
Developing Web Apps in SAS Visual Analytics |
Jim Box, Samiul Haque |
source |
9 |
| PharmaSUG |
2024 |
How to generate a submission ready ADaM for complex data |
Yilan Xu, Hu Qu, Tina Wu |
source |
8 |
| PharmaSUG |
2024 |
Oncology ADaM Datasets Creation Using R Programming: A Comprehensive Approach |
Ishwar Chouhan |
source |
29 |
| PharmaSUG |
2024 |
Programming Considerations in Deriving Progression-Free Survival on Next-Line Therapy (PFS2) |
Alec McConnell, Yun Peng |
source |
5 |
| PHUSE US |
2024 |
Are Platform Studies the Need of the Hour for Oncology Trials? |
Vidya Muthukumar |
source presentation source |
2 |
| PHUSE US |
2024 |
Confirmation and Cancellation - Best Strategies for Data Collection and Handling within Solid Tumor Studies Using RECIST 1.1 and iRECIST Guidelines |
Sherry Ye, Abraham Yeh |
source presentation source |
10 |
| PHUSE US |
2024 |
Eliminating Duplicative Maintenance of Statistical Programs In Parallel Analyses Using a Single Control File |
Kavitha Boinapally |
source poster source |
4 |
| PHUSE US |
2024 |
InnoRand - Innovative Randomisation |
Yinfei Wu, Ivo Marek |
source presentation source |
4 |
| PHUSE EU |
2023 |
Efficacy Endpoints in Adjuvant and Neo-Adjuvant Oncology Trials |
Yuliia (Piddubna) Cherednichenko, Anna Amosova |
source presentation source |
15 |
| PHUSE EU |
2023 |
Interaction with the FDA During and After a Type C Meeting, From the Perspective of a Statistical Programmer |
Dieter Hartz |
source presentation source |
5 |
| WUSS |
2023 |
Visualizing Insights, Empowering Discoveries: SAS Viya Unleashed in Life Science Analytics |
Matthew J. Becker |
source |
13 |
| SESUG |
2023 |
BLINDED STUDIES AND CHALLENGES |
Jalender Reddy Musku, Srinivas Tiyyagura |
source |
5 |
| SESUG |
2023 |
SAS Macro for Randomization-Based Methods for Covariance and Stratified Adjustment of Win Ratios and Win Odds for Ordinal Outcomes |
Elaine Kowalewski, Ann Marie K. Weideman, Gary G. Koch |
source |
11 |
| PharmaSUG |
2023 |
A model for sponsors to support independent operation of IDMCs in clinical trials. |
Bhanu Bayatapalli, Yiyi Chen |
source |
8 |
| PharmaSUG |
2023 |
ADaM Design and Programming Standardization for Oncology Efficacy Endpoints Based on RECIST 1.1 |
Ellen (Zihui) Lin, Matt Ness, Yinghui Wang |
source |
9 |
| PharmaSUG |
2023 |
Admiralonco - The Cross-Company R Package for Oncology Admirers |
Neharika Sharma, Matthew Marino |
source |
25 |
| PharmaSUG |
2023 |
Data Doesn't Lie - Real Time Monitoring and Projecting on Clinical Trial Enrollment Progression |
Wenjun He |
source |
5 |
| PharmaSUG |
2023 |
Shifting the drug development paradigm with Adaptive Design and master protocol |
Aman Bahl |
source |
16 |
| PharmaSUG |
2023 |
Survival Methods for Crossover in Oncology Trials |
Brian Mosier |
source |
18 |
| PHUSE EU |
2022 |
Adaptive Design - Better Bend Than Break [presentation] |
Albin John, Athira Sudhakar |
source |
15 |
| SESUG |
2022 |
A SAS Macro to Calculate Blinding Index in Clinical Trials: %blinding_index, an application of PROC IML |
Jingwei Wu, Di Zhu |
source |
7 |
| PharmaSUG |
2022 |
Automation using SAS Makes it Easy to Monitor Dynamic Data in Clinical Trial |
Wenjun He |
source |
9 |
| PharmaSUG |
2022 |
Derivation of Efficacy Endpoints by iRECIST Criteria: A Practical Approach |
Ilya Krivelevich, Lei Gao, Richard Kennan |
source |
9 |
| PharmaSUG |
2022 |
Following Your Footsteps: Maintaining Traceability in ADaM Datasets |
Nancy Brucken, Karl Miller |
source |
58 |
| PharmaSUG |
2022 |
How to create SDTM SAS transport datasets using Python |
Kevin Lee |
source |
8 |
| PharmaSUG |
2022 |
Merging Pharmacokinetic (PK) Sample Collection and Dosing Information for PK Analysis based on Study Design and lessons learned |
Durga Kalyani Paturi |
source |
11 |
| PharmaSUG |
2022 |
Quality Control With External Code |
Bill Coar |
source |
7 |
| PharmaSUG |
2022 |
Quality Gates: An Overview from Clinical SAS Programming Perspective |
Nagadip Rao, Pavan Jupelli |
source |
10 |
| PHUSE US |
2022 |
Real-time Interactive Dashboard for Clinical Trials [presentation] |
Kris Liu |
source |
9 |
| PHUSE US |
2022 |
Safety First, Agility Comes: Challenges and Solutions to Fulfilling IND Safety Requirements |
Hong Wang, Ke Xiao |
source presentation source |
7 |
| PHUSE EU |
2021 |
Statistical Training for Health Technology Assessment Statistical Programmers |
Anastasia Kokoreva, William Malbecq |
source video presentation source |
7 |
| SESUG |
2021 |
Back to Basics: Running an Analysis from Data to Refinement in SAS |
Deanna Naomi Schreiber-Gregory |
source |
21 |
| PharmaSUG |
2021 |
Back to Basics: Running an Analysis from Data to Refinement in SAS |
Deanna Naomi Schreiber-Gregory |
source |
21 |
| PharmaSUG |
2021 |
No Black Boxes: An Utterly Transparent Batch Randomization System in R |
Dennis Sweitzer |
source |
12 |
| PharmaSUG |
2021 |
Survival Statistics with PROC LIFETEST and PROC PHREG: Pitfall-Avoiding Survival Lessons for Programmers |
Yun (Julie) Zhuo |
source |
10 |
| PharmaSUG |
2021 |
Willing to Play with William-s Design: An Exemplification of Randomization Schedule Generation using SAS |
Abhyuday Chanda |
source |
12 |
| SGF |
2021 |
Back to Basics: Running an Analysis from Data to Refinement in SAS |
Deanna Naomi Schreiber-Gregory |
source presentation |
20 |
| SGF |
2021 |
Modeling Causal Effects Using SAS/STAT |
John Amrhein, McDougall Scientific |
source |
21 |
| PHUSE EU |
2020 |
ADaM is Back: The New ADaM IG 1.2 and Beyond |
Angelo Tinazzi |
source video |
8 |
| PHUSE EU |
2020 |
Analysis Used in RBM [presentation] |
Aminul Islam, Shafi Chowdhury |
source video |
8 |
| PHUSE EU |
2020 |
Brace Yourself for Smooth Unblinding [presentation] |
Vladyslav Khudov |
source video |
26 |
| PHUSE EU |
2020 |
SUPPQUAL Datasets: The Good, the Bad and the Ugly [presentation] |
Sergiy Sirichenko |
source video |
40 |
| SESUG |
2020 |
A Doctor's Dilemma: How Propensity Scores Can Help Control for Selection Bias in Medical Education |
Deanna Naomi Schreiber-Gregory |
source |
13 |
| SGF |
2020 |
A Doctor's Dilemma: How Propensity Scores Can Help Control for Selection Bias in Medical Education |
Deanna Naomi Schreiber-Gregory |
source |
13 |
| PharmaSUG |
2020 |
A Doctor's Dilemma: How Propensity Scores Can Help Control for Selection Bias in Medical Education |
Deanna Naomi Schreiber-Gregory |
source |
14 |
| PharmaSUG |
2020 |
End-to-end Prostate-Specific Antigen (PSA) Analysis in Clinical Trials: From Mock-ups to ADPSA |
Joy Zeng, Varaprasad Ilapogu, Xinping Cindy Wu |
source |
12 |
| PharmaSUG |
2020 |
Overcoming Pitfalls of DS: Shackling the 'Elephant in the room' |
Soumya Rajesh, Michael Wise |
source |
9 |
| PharmaSUG |
2020 |
Principal Stratum strategy for handle intercurrent events: a causal estimand to avoid biased estimates |
Andrea Nizzardo, Giovanni Marino Merlo, Simona Scartoni |
source |
13 |
| PharmaSUG |
2020 |
Trial Sets in Human Clinical Trials |
Fred Wood |
source |
13 |
| PharmaSUG |
2020 |
Untangling the Subject Elements Domain |
Christine McNichol |
source |
8 |
| PharmaSUG |
2020 |
Using SAS Simulations to determine appropriate Block Size for Subject Randomization Lists |
Kevin Venner, Jennifer Ross, Kyle Huber, Noelle Sassany, Graham Nicholls |
source |
10 |
| PHUSE US |
2020 |
Adverse Event and Treatment Emergent Approaches in the Industry |
Aimee Basile |
source poster source |
11 |
| PHUSE US |
2020 |
Be the Master for a Master Protocol Study |
Ke Xiao |
source poster source |
8 |
| PHUSE US |
2020 |
Confusing Data Validation Rules Explained, Part 2 |
Michael Beers, Blue Bell |
source |
6 |
| PHUSE US |
2020 |
Design and Conduct of Clinical Trials: Past Present and Future. New Innovative Technology Methods |
George Obsekov |
source presentation source |
12 |
| PHUSE US |
2020 |
Great!! Not So Great ... How to Capture it All in an Effective Lessons Learned Discussion |
Monali Khanna |
source presentation source |
7 |
| PHUSE US |
2020 |
Let Us Trace Back to the Beginning from the End |
Madhusudhan Reddy Papasani, Swathi Kotla |
source presentation source |
12 |
| PHUSE US |
2020 |
Untangling the Subject Elements Domain |
Christine McNichol |
source presentation source |
7 |
| PHUSE EU |
2019 |
Analysis of composite endpoints using the Win-Ratio method in SAS |
Murat Ipek |
source presentation source |
8 |
| PHUSE EU |
2019 |
Sub-population Detection Using Graph-based Machine Learning |
Sergey Glushakov, Kostiantyn Drach |
source |
28 |
| PharmaSUG |
2019 |
Camouflage your Clinical Trial with Machine Learning and AI |
Ajith Baby Sadasivan, Limna Salim, Akhil Vijayan, Anoop Ambika |
source |
10 |
| PharmaSUG |
2019 |
Enhancing Randomization Methodology Decision-Making with SAS Simulations |
Kevin Venner, Jennifer Ross, Kyle Huber, Graham Nicholls |
source |
15 |
| PharmaSUG |
2019 |
Forewarned is forearmed or how to deal with ADSL issues |
Anastasiia Oparii |
source |
16 |
| PharmaSUG |
2019 |
Jump Start your Oncology knowledge |
Xiaoyin Zhong, Feng Liu |
source |
9 |
| PharmaSUG |
2019 |
Progression-Free Survival (PFS) Analysis in Solid Tumor Clinical Studies |
Na Li |
source |
14 |
| PharmaSUG |
2019 |
Useful SAS techniques in Efficacy Analysis for Oncology studies |
Joy Zeng |
source |
21 |
| SGF |
2019 |
The Benefits of Keeping It Casual: Investigating Stress-Mediated Health Outcomes with PROC CAUSALMED |
Daniel Muzyka, Matthew Lypka |
source |
19 |
| PHUSE US |
2019 |
A SAS Macro for Variable Ratio Treatment vs. Placebo in Propensity Score Matching |
Punjita Baranwal, Prashant Kulkarni |
source presentation source |
13 |
| PHUSE US |
2019 |
Misuse and Misapplication in Statistical Data Analysis - A Topic that Never Goes Out of Style |
Corinna Miede |
source presentation source |
12 |
| PHUSE EU |
2018 |
Practical Benefits of EC: Building a Comprehensive Exposure Story |
Zegher Vereecke, Donald Benoot |
source presentation source |
5 |
| PHUSE US |
2018 |
ADaM Intermediate Dataset: How to Improve Your Analysis Traceability |
Angelo Tinazzi, Ashish Aggarwal |
source presentation source |
12 |
| PHUSE US |
2018 |
How do I have ONE Interpretation of CDISC for all my Studies? |
Mor Meyerovich |
source presentation source |
5 |
| PHUSE US |
2018 |
Practical Benefits of EC: Building a Comprehensive Exposure Story |
Donald Benoot, Zegher Vereecke |
source |
5 |
| PHUSE US |
2018 |
Subgroup Explorer and AdEPro - The Full Picture on Clinical Trial Data [presentation] |
Madhurima Majumder, Erya Huang |
source |
20 |
| PharmaSUG |
2018 |
ADINTDT and ADTTE for Survival Sweep in Oncology Studies |
Christine S Teng, Wenyu Hu |
source |
6 |
| PharmaSUG |
2018 |
An Efficient Tool for Clinical Data Check |
Chao Su |
source |
8 |
| PharmaSUG |
2018 |
Analysis of Oncology Studies for Programmers and Statisticians |
Kevin Lee |
source |
7 |
| PharmaSUG |
2018 |
Building Simulated CRF Data for Study Mock-Ups |
Ashley Kesler, Hisham Madi, Jonathan W. Duggins, James E. Blum |
source |
10 |
| PharmaSUG |
2018 |
Data Management and CDISC Formatting for Transdermal Patches |
Lois Lynn |
source |
11 |
| PharmaSUG |
2018 |
Implementing the Rank-Preserving Structural Failure Time Model in SAS and R |
Bradford J. Danner, Indrani Sarkar |
source |
8 |
| PharmaSUG |
2018 |
Sense and Censorability: Learn censoring techniques with ADTTE for your survival |
Shilpakala Vasudevan |
source |
12 |
| SGF |
2018 |
Robust Tuning for Machine Learning |
Alex Glushkovsky |
source |
22 |
| SESUG |
2017 |
A Macro for Generating the Adverse Events Summary for ClinicalTrials.gov |
Andrew Moseby, Maya Barton |
source |
7 |
| SESUG |
2017 |
Statistician's secret weapon: 20 ways of detecting raw data issues |
Lixiang Larry Liu |
source |
8 |
| SESUG |
2017 |
Timing Variables In Clinical Trials: Avoiding Common Mistakes And Dealing With Unforeseen Issues |
Gregory Weller |
source |
4 |
| SCSUG |
2017 |
Risk Based Monitoring (RBM) with SAS Visual Analytics |
Prasoon Sangwan, Piyush K. Singh, Faraz Khan |
source |
10 |
| PHUSE EU |
2017 |
Assessing New CFDA Requirements on Data Integrity Using Risk-Based Monitoring and Enrollment Patterns |
Wenjun Bao, Richard C. Zink, Geoffrey A. Mann |
source presentation source |
13 |
| PHUSE EU |
2017 |
Decrypting SDTM Trial Design Datasets for Complex Study Designs |
Charumathy Sreeraman |
source presentation source |
14 |
| PHUSE EU |
2017 |
FlexRandomizer: Easy Randomisation in Real Time |
Priyadarshan Shinde, Mangesh Kulkarni |
source presentation source |
12 |
| PHUSE EU |
2017 |
Managing Study Workflow Using the Resource Description Framework (RDF) |
Armando Oliva |
source |
7 |
| MWSUG |
2017 |
Waterfall Plots in Oncology Studies in the Case of Multi-Arms Design |
Ilya Krivelevich, Kalgi Mody, Simon Lin |
|
15 |
| PharmaSUG |
2017 |
Data Monitoring Committee Report Programming: Considering a Risk-Based Approach to Quality Control |
Amber Randall, Bill Coar |
source |
9 |
| PharmaSUG |
2017 |
Overview and Application of the HCV Vertical Resistance Analysis Template |
Yan Xie |
source |
5 |
| PharmaSUG |
2017 |
SAS Macro for Derivation of Best Overall Response per RECIST v. 1.1 |
Bob Zhong, Jiangfan Li, Hong Xie, Peter De Porre, Kenneth Maahs, Kyounghwa Bae |
source |
9 |
| PharmaSUG |
2017 |
Statistician's secret weapon: 20 ways of detecting raw data issues |
Lixiang Larry Liu |
source |
8 |
| PharmaSUG |
2017 |
Visualizing Enrollment Over Time |
Laura Gruetzner |
source |
11 |
| SGF |
2017 |
Differentiate Effects from the Noise of Promotional Marketing Campaigns |
Alex Glushkovsky, Matthew Fabian |
source |
9 |
| SGF |
2017 |
SAS: A Unifying Tool That Manages Hospital and Research Pharmacy Data and Reporting |
Robert MacArthur, Arman Altincatal |
source pdf |
8 |
| SESUG |
2016 |
In the Pursuit of Balanced Groups: A SAS Macro for an Adaptive Randomization Test |
Tyler Hicks, Jeffrey D. Kromrey |
source |
9 |
| SESUG |
2016 |
SDTM What? ADaM Who? A Programmer's Introduction to CDISC |
Venita DePuy |
source |
9 |
| PHUSE EU |
2016 |
EnForeSys - An Advanced Patient Enrolment Forecaster with Monte Carlo Simulations |
Ritika Yadav, Swechhya Bista |
source presentation source |
12 |
| WUSS |
2016 |
Selection Bias: How Can Propensity Score Utilization Help Control For It? |
Deanna Naomi Schreiber-Gregory |
source |
13 |
| WUSS |
2016 |
Why and What Standards for Oncology Studies (Solid Tumor, Lymphoma and Leukemia)? |
Kevin Lee |
source |
7 |
| PharmaSUG |
2016 |
Creating Time to Event ADaM Dataset for a Complex Efficacy Endpoint in Multiple Sclerosis Therapeutic Area |
Ittai Rambach |
source |
8 |
| PharmaSUG |
2016 |
Scrambled Data - A Population PK/PD Programming Solution |
Sharmeen Reza |
source |
8 |
| PharmaSUG |
2016 |
The Standard for the Exchange of Nonclinical Data (SEND): History, Basics, and Comparisons with Clinical Data |
Fred Wood |
source |
10 |
| MWSUG |
2015 |
Using SAS for the Longitudinal Analysis of Difference Scores |
Brandy R. Sinco, Edith Kieffer, Michael S. Spencer, Gloria Palmisano, Gretchen Piatt, Michele Heisler |
|
14 |
| SESUG |
2015 |
Multilevel Randomization |
Marina Komaroff, Lois Lynn |
source |
10 |
| PharmaSUG CN |
2015 |
Reading and Resolving OpenCIDSC Message [presentation] |
Yu Pang |
|
23 |
| PharmaSUG |
2015 |
Analysis Methods for a Sequential Parallel Comparison Design (SPCD) |
Harry Haber, James Zuazo, Linda LaMoreaux |
source |
11 |
| PharmaSUG |
2015 |
Missing Data For Repeated Measures: Single Imputation VS Multiple Imputation |
Giulia Tonini, Simona Scartoni, Camilla Paoli, Andrea Nizzardo, Angela Capriati |
source |
10 |
| PharmaSUG |
2015 |
Multilevel Randomization |
Marina Komaroff, Lois Lynn |
source |
10 |
| PharmaSUG |
2015 |
Team-work and Forensic Programming: Essential Foundations of Indestructible Projects |
Brian P. Fairfield-Carter |
source |
14 |
| PharmaSUG |
2015 |
Two different use cases to obtain best responses using RECIST 1.1: SDTM and ADaM |
Kevin Lee, Vikash Jain |
source |
17 |
| SGF |
2015 |
Adaptive Randomization Using PROC MCMC |
Qianyi Huang, John Amrhein |
source |
13 |
| SGF |
2015 |
Experimental Approaches to Marketing and Pricing Research |
Max Friedauer, Jason Greenfield, Yuhan Jia, Joseph Thurman |
source |
22 |
| SGF |
2015 |
Permit Me to Permute: A Basic Introduction to Permutation Tests with SAS/IML Software |
John Vickery |
source |
15 |
| SGF |
2015 |
Random vs. Fixed Effects: Which Technique More Effectively Addresses Selection Bias in Observational Studies |
Jessica Navratil-Strawn, Stephen Hartley, Ronald J. Ozminkowski |
source zip |
8 |
| SGF |
2015 |
Using SAS to Deliver Web Content Personalization Using Cloud-Based Clickstream Data and On-premises Customer Data |
Mahesh Subramanian, Suneel Grover |
source |
24 |
| SESUG |
2014 |
A Comprehensive Automated Data Management System For Clinical Trials |
Heather F. Eng, Jason A. Lyons, Theresa M. Sax |
source |
12 |
| SESUG |
2014 |
SDTM What? ADaM Who? A Programmer's Introduction to CDISC |
Venita DePuy |
source |
9 |
| PHUSE EU |
2014 |
Checking Symmetry in Predefined Time Assessments |
Antonio Nieto, José Luis Jiménez Moro |
source presentation source |
9 |
| PHUSE EU |
2014 |
Data Challenges in Adaptive Trials |
Claudio Garutti |
source presentation source |
5 |
| MWSUG |
2014 |
A Comprehensive Automated Data Management System For Clinical Trials |
Heather F. Eng, Jason A. Lyons, Theresa M. Sax |
|
12 |
| MWSUG |
2014 |
Comparing regression, propensity matching and coarsened exact matching in healthcare observational studies using SAS: An example from the Medical Expenditure Panel Survey (MEPS) |
Douglas Thompson |
|
16 |
| MWSUG |
2014 |
Using The Delta Method With Proc Mixed To Generate Means And Confidence Intervals From A Linear Mixed Model On The Original Scale, When The Analysis Is Done On The Log Scale |
Brandy R. Sinco, Edith Kieffer, Michael S. Spencer |
|
11 |
| PharmaSUG |
2014 |
An ADaM Interim Dataset for Time-to-Event Analysis Needs |
Tom Santopoli, Kimberly Minkalis, Sandra Minjoe |
source |
9 |
| PharmaSUG |
2014 |
Clinical Study Report Review: Statistician's Approach |
Amita Dalvi |
source |
6 |
| PharmaSUG |
2014 |
Defensive Programming, Avoiding the Big Mistakes |
David W. Franklin |
source |
11 |
| PharmaSUG |
2014 |
Methodology for Non-Randomized Clinical Trials: Propensity Score Analysis |
Dan Conroy |
source |
5 |
| PharmaSUG |
2014 |
Using the Power of SAS SQL |
Jessica Wang |
source |
14 |
| SGF |
2014 |
Adjusting Clustering: Minimize Your Suffering! |
Brenda Beaty, L. Miriam Dickinson |
source |
9 |
| SGF |
2014 |
Analyzing Data from Experiments in Which the Treatment Groups Have Different Hierarchical Structures |
Sharon Lohr, Peter Schochet |
source |
12 |
| SESUG |
2013 |
A SAS Macro for Finding Optimal k-Means Clustering in One Dimension with Size Constraints |
Fengjiao Hu |
source |
5 |
| PHUSE EU |
2013 |
Define-XML v2 - What's New |
Lex Jansen |
source presentation source |
15 |
| PHUSE EU |
2013 |
Efficacy Endpoints in Oncology |
Angelo Tinazzi |
source |
9 |
| MWSUG |
2013 |
Using SAS in Clinical Programming Project Management from Excel Spreadsheets |
Jean Crain |
|
13 |
| PharmaSUG |
2013 |
ADaM Datasets for Graphs |
Kevin Lee, Chris Holland |
source |
15 |
| PharmaSUG |
2013 |
Adjusted proportion difference and confidence interval in stratified randomized trials |
Yeonhee Kim, Seunghyun Won |
source |
8 |
| PharmaSUG |
2013 |
Doctoring Your Clinical Trial with Adaptive Randomization: SAS Macros to Perform Adaptive Randomization |
Jenna Colavincenzo |
source |
9 |
| PharmaSUG |
2013 |
SAS Programmer to Clinical SAS Programmer |
Gayatri Karkera, Nehan Mohan |
source |
7 |
| SGF |
2013 |
Doctoring Your Clinical Trial with Adaptive Randomization: SAS Macros to Perform Adaptive Randomization |
Jenna Colavincenzo |
source |
9 |
| NESUG |
2012 |
A Visual Approach to Monitoring Case Report Form Submission During Clinical Trials |
Rebecca Horney, Karen Jones, Annette Wiseman |
|
7 |
| PHUSE EU |
2012 |
"Bertha.sas" - User Friendly Ways to get Traceability |
Elena Glathe |
source presentation source |
28 |
| PHUSE EU |
2012 |
Improving Data Management with Systems Integration and Next Generation Data Flow |
Richard Davies |
source presentation source |
4 |
| SESUG |
2012 |
A Randomization Test SAS/IML Program for Making Treatment Effects Inferences for Extensions and Variations of ABAB Single-Case Experimental Designs |
Patricia Rodríguez de Gil, John M. Ferron |
source |
8 |
| SESUG |
2012 |
A Visual Approach to Monitoring Case Report Form Submission During Clinical Trials |
Rebecca Horney, Perry Point |
source |
7 |
| WUSS |
2012 |
Up To Speed With Categorical Data Analysis |
Maura E. Stokes |
source |
25 |
| PharmaSUG |
2012 |
A SAS Tool to Allocate and Randomize Samples to Illumina Microarray Chips |
Huanying Qin, Greg Stanek, Derek Blankenship |
source |
6 |
| SESUG |
2011 |
Permutated-block randomization with varying block sizes using SAS Proc Plan |
Lei Li |
source |
6 |
| WUSS |
2011 |
SAS Program as a Backup Tool for an Adaptive Randomization System |
Yajie Wang |
source |
9 |
| WUSS |
2011 |
Up To Speed With Categorical Data Analysis |
Maura E. Stokes |
source |
25 |
| PHUSE EU |
2011 |
Access Control Execution Systems (ACES) |
Shailesh Kulthe, Eric Silva |
source |
10 |
| MWSUG |
2011 |
Using a Double DOW Loop to Compute Progression Free Survival |
Matthew Nizol |
|
9 |
| NESUG |
2011 |
A Practical Method to Generate Desirable Group Sizes by Performing Adaptive Randomization |
Feifei Yang |
|
5 |
| NESUG |
2011 |
Adaptive Randomization: Institutional Balancing Using SAS Macro |
Rita Tsang, Katherine Kacena |
|
12 |
| PharmaSUG |
2011 |
Using the ADaM Basic Data Structure for Survival Analysis |
Nancy Brucken, Sandra Minjoe, Mario Widel |
source |
5 |
| SGF |
2011 |
Randomizing Small Strata Groups: Balancing Baseline Population Measures While Staying True to a Chosen Allocation Strategy, an Alternative to PROC SURVEYSELECT |
Gregg M. Oginz |
source |
12 |
| SGF |
2011 |
Up To Speed With Categorical Data Analysis |
Gary G. Koch, Maura E. Stokes |
source |
25 |
| NESUG |
2010 |
Delivering a Simple Randomization list using RTF |
MinJung Yoon |
|
5 |
| NESUG |
2010 |
Macro for Computing Complier-Average Causal Effect of Treatment (CACE) Using Instrumental Variable Method |
Patricia R. Houck, Sati Mazumdar, Benoit H. Mulsant |
|
3 |
| NESUG |
2010 |
Using SAS for Design of Experiments: An Unbalanced Incomplete Block Design |
Burhan Ogut |
|
7 |
| WUSS |
2010 |
Blocked Randomization with Randomly Selected Block Sizes: A Flexible SAS Macro |
Jimmy Thomas Efird |
source |
3 |
| SESUG |
2010 |
Proc Report Data = Subject.Event_Chronology; |
Christina Carty, Elizabeth R. Spence |
source |
12 |
| PharmaSUG |
2010 |
%disposition_plot: A Macro Application for Clinical Study Disposition Analysis |
Yao Huang |
|
8 |
| SGF |
2010 |
The Best of Both Worlds: Designing Experiments in the JMP and SAS Environment |
Jose G. Ramirez |
source |
12 |
| SESUG |
2009 |
SAS and Clinical IVRS: Beyond Schedule Creation |
Gayle Flynn |
source |
10 |
| PHUSE EU |
2009 |
Timezone correction of data |
John van Bemmelen |
source |
3 |
| WUSS |
2009 |
Don't Be Loopy: Re-Sampling and Simulation the SAS Way |
David L. Cassell |
source |
18 |
| PharmaSUG |
2009 |
Don't Be Loopy: Re-Sampling and Simulation the SAS Way |
David L. Cassell |
|
18 |
| PharmaSUG |
2009 |
SAS 1-liners |
Stephen Hunt |
|
6 |
| SGF |
2009 |
Designing Experiments for the Process |
George A. Milliken |
source |
27 |
| SGF |
2009 |
Designing Multi-Step Fractional Factorial Split-Plots: A Combined JMP and SAS User Application |
Jose G. Ramirez, Jon T. Weisz |
source |
11 |
| WUSS |
2008 |
Using Propensity Scores To Adjust For Treatment Selection Bias |
R. Scott Leslie |
source |
7 |
| PHUSE EU |
2008 |
A gentle introduction to Survival Analysis |
Martin Scottt, Angelo Tinazzi |
source |
13 |
| MWSUG |
2008 |
Creating Macros for Survival Data in Oncology Study |
Jagannath Ghosh |
|
8 |
| WUSS |
2007 |
A SAS Algorithm for Block Randomization |
Jimmy Thomas Efird, Miki Hong, Pollie Bith-Melander, Chieko Kimata, Caroline Jiang, Kathleen Baker |
source |
4 |
| WUSS |
2007 |
Don't Be Loopy: Re-Sampling and Simulation the SAS Way |
David L. Cassell |
source |
18 |
| PNWSUG |
2007 |
Don't Be Loopy: Re-Sampling and Simulation the SAS Way |
David L. Cassell |
|
18 |
| PharmaSUG |
2007 |
A Review of Propensity Score Application in Healthcare Outcome and Epidemiology |
Guiping Yang |
|
24 |
| PharmaSUG |
2007 |
Randomization Schedules - Made Easy |
Michael Stout |
|
10 |
| SGF |
2007 |
Don't Be Loopy: Re-Sampling and Simulation the SAS Way |
David L. Cassell |
source |
18 |
| SGF |
2007 |
Local and Global Optimal Propensity Score Matching |
Marcelo Coca-Perraillon |
source |
9 |
| SGF |
2007 |
Split and Conquer! Using SAS/QC to Design Quality into Complex Manufacturing Processes |
Jose G. Tobias, Randall D. Ramirez |
source |
25 |
| PharmaSUG |
2006 |
A Case of Online Data Processing and Statistical Analysis via SAS/IntrNet |
Sijian Zhang |
|
8 |
| PharmaSUG |
2006 |
Patient Profile: A Menu-Driven System |
Adel Fahmy |
|
12 |
| PharmaSUG |
2006 |
Randomization in Clinical Trial Studies |
David Shen, Zaizai Lu |
|
8 |
| PharmaSUG |
2006 |
Sample Size Calculation and Timeline Estimate for Progression-Free Survival |
Chung-Kuei Chang |
|
10 |
| SUGI |
2006 |
Using the SAS System for Experimental Designs for Multi-Component Interventions in Medicine |
Heather G. Allore, Peter Peduzzi, Ling Han, Mary Tinetti |
source |
7 |
| PNWSUG |
2005 |
Extreme Graphics Make Over: Using SAS/GRAPH to Get the Graphical Output You Need |
Miriam G. Cisternas, Arthur L. Carpenter |
|
16 |
| PHUSE EU |
2005 |
Splendida fugilente oculi, e.g. dummy randomization lists to more than designed patient profiles |
Magnus Mengelbier |
source |
5 |
| PHUSE EU |
2005 |
The Future of CDISC |
Becky Kush |
source |
50 |
| WUSS |
2005 |
Extreme Graphics Make Over: Using SAS/GRAPH to Get the Graphical Output You Need |
Miriam G. Cisternas, Arthur L. Carpenter |
source |
16 |
| NESUG |
2005 |
Introduction to Experimental Design using SAS |
Jonas V. Bilenas |
|
13 |
| PharmaSUG |
2005 |
A Dynamic SAS/IntrNet Example with Help of ASP and JavaScript: Online Clinical Trial Randomization List Generator |
Sijian Zhang, Mark Carpenter, Michael Windle |
|
6 |
| PharmaSUG |
2005 |
Analyze Group-randomized Trial Data with Binary Outcome Using Weighted Paired t-test: A SAS Macro |
Don (Dongguang) Li |
|
5 |
| PharmaSUG |
2005 |
Create Your Customized Case Report Form (CRF) Tracking System |
Tikiri B. Karunasundera |
|
9 |
| SUGI |
2005 |
Extreme Graphics Make Over: Using SAS/GRAPH to Get the Graphical Output You Need |
Miriam G. Cisternas, Arthur L. Carpenter |
source |
16 |
| NESUG |
2004 |
Minimization: Testing a Dynamic Randomizaton Algorithm |
Donna E. Levy, Emily Blood |
|
15 |
| MWSUG |
2004 |
The Randomization Test Procedure: Testing for a Non-Zero Quadratic Effect |
Ling Huang, Paul W. Johnson |
|
8 |
| PharmaSUG |
2004 |
Clinical Trial Randomization Design: Blocked Randomized Response Adaptive Method |
K.Y. Trudy Poon |
|
4 |
| SUGI |
2004 |
A SAS Macro for Generating Randomization Lists in Clinical Trials Using Permuted Blocks Randomization |
Mazen Abdellatif |
source |
12 |
| SUGI |
2004 |
Some Statistical Strategies for Analyzing Confirmatory Studies Involving One or More Occurrences of Primary Events |
Gary G. Koch, Maura E. Stokes |
source |
21 |
| WUSS |
2003 |
Clinical Trial Randomization Design: Blocked Randomized Response Adaptive Method |
K.Y. Trudy Poon, Che-Chin Lie |
source |
4 |
| PharmaSUG |
2003 |
Implementing Constrained or Balanced-Across-the-Centers Randomization with SAS v8 Procedure PLAN |
Cindy Q. Song, Olga M. Kuznetsova |
|
8 |
| PharmaSUG |
2003 |
Sneak Peek: Previewing Blinded Study Results |
Amy Rhoads Underwood |
|
4 |
| SUGI |
2003 |
Multilevel Designs and Their Analyses |
George A. Milliken |
source |
|
| SUGI |
2003 |
Using the SAS System to Construct and Operate Control Charts with Randomized Control Limits |
Peter S. Wludyka |
source |
7 |
| MWSUG |
2002 |
Using SAS System to Geneerate Customized Kaplan-Meieer Curves and its Applciation to Presentation in Clinical Research |
Daojun Mo, Yiyong Fu |
|
14 |
| NESUG |
2002 |
An Animated Guide: Matching Test & Control Subjects |
Russell M. Lavery, Glenn Abrahamsen |
|
21 |
| SESUG |
2002 |
A GUI System for the Generation of Clinical Trial Randomization Plans for Collaborative Multi-institutional Clinical Trials |
Sijian Zhang, Mark Carpenter, John W. Gnann |
source |
3 |
| WUSS |
2002 |
A Randomization-Test Wrapper for SAS PROCs |
Christopher F. Ake, David L. Cassell |
source |
4 |
| SUGI |
2002 |
A Randomization-Test Wrapper for SAS PROCs |
David L. Cassell |
source |
4 |
| SUGI |
2002 |
Generating Randomization Schedules Using SAS Programming |
Chunqin Deng, Julia C. Graz |
source |
6 |
| SUGI |
2002 |
Using SAS to Perform Robust I-Sample Analysis of Means Type Randomization Tests for Variances for Unbalanced Designs |
Peter S. Wludyka, Ping Sa |
source |
7 |
| NESUG |
2001 |
Recursion? SAS? Let.s Fake It! |
Stephen J. Rhoades |
|
6 |
| SCSUG |
2001 |
Creating Visit Specific CRF Checklists for a Longitudinal Study |
Emily A. Mixon, Karen B. Fowler |
|
4 |
| PharmaSUG |
2001 |
Leveraging Existing SAS Programs for Wireless Delivery |
Deborah A. Testa, Russell Holmes |
|
3 |
| SUGI |
2001 |
A SAS Macro to Isolate All Date Values from a Data Library into a SAS Dataset |
Michael L. White |
source |
2 |
| SUGI |
2001 |
A SAS Program to Perform Adaptive Randomization |
Carey G. Smoak, Jin-Sying Lin |
source |
2 |
| SUGI |
2001 |
Wireless SAS Applications for Tracking Clinical Research |
Deborah A. Testa, Russell Holmes |
source |
3 |
| SESUG |
2000 |
Using SAS to Perform Robust I-Sample Analysis of Means Type Randomization Tests for Variances |
Peter S. Wludyka |
source |
6 |
| SUGI |
2000 |
A Randomization Test: Somatic Cell Count Slope Comparisons of 55 California Dairies |
Paul W. Johnson |
source |
4 |
| SUGI |
2000 |
Dynamic Dataset Selection and Project Management using SAS 6.12 and the Windows NT 4.0 File System |
Matthew T. Downs, Heidi M. Christ-Schmidt |
source |
5 |
| SUGI |
2000 |
Robust Effect Size Estimates and Meta-Analytic Tests of Homogeneity |
Kristine Y. Hogarty, Jeffrey D. Kromrey |
source |
6 |
| SESUG |
1999 |
Using SAS/AF to Create Applications for the Administrative Aspects of Data Management in Clinical Trials |
Emily A. Mixon, Karen B. Fowler, Felicita David |
source |
4 |
| SUGI |
1999 |
A SAS Module/Macro Program for Computing Statistical Power Curves for Detecting Treatment Effect |
David Olaleye |
source |
6 |
| SUGI |
1999 |
Using the Mixed Procedure to Analyze a Fractional Factorial Split-Plot Experiment |
Jon M. Lindenauer |
source |
4 |
| SESUG |
1998 |
A SAS Macro Program to Perform Permutation Testing for Group*Time Interaction in an Unbalanced Repeated-Measures Analysis of Variance |
Mark S. Litaker, Bernard Gutin |
|
5 |
| SEUGI |
1998 |
PROC TABULATE in a real WinWord table: a freeware macro |
Roger Calvez |
source |
6 |
| NESUG |
1997 |
Survival Analysis: Non-Traditional Applications for Non-Statisticians |
Margaret Ann Goetz |
|
5 |
| SUGI |
1997 |
Building an Online Information Processing System Using SAS Software and a UNIX Shell Script |
Annie S. Guo, Long Ngo |
source |
6 |
| WUSS |
1996 |
SAS PROC MIXED to Fit Growth Curve Models: Application to a Longitudinal Group Randomization Study |
Biao Wm. Lu, Sandra Wilson, David Latini, David Dayton |
source |
6 |
| SUGI |
1996 |
From Report and Analysis Plan to SAS Report Programs - The Mass Production of Report Skeleton Programs |
Sam X. Ye |
source |
7 |
| SUGI |
1996 |
Using PROC PLAN for Randomization Assignments |
Miriam W. Rosenblatt |
source |
5 |
| MWSUG |
1995 |
Randomization and Analysis of Body Weights in Rodent Toxicity Studies |
Jen-Fue Maa |
|
6 |
| MWSUG |
1995 |
Using PROC PLAN for Randomization Assignments |
Miriam W. Rosenblatt |
|
6 |
| NESUG |
1995 |
When Chi-Square Does Not Hold: How to Analyze Tables With Low Cell Frequencies With SAS |
Lothar Tremmel |
|
9 |
| SUGI |
1995 |
Maintaining Blinding in the Presence of Blocking and Identifiable Treatments |
Sharon Barker |
source |
3 |
| MWSUG |
1994 |
SAS Randomization Techniques for Clinical Trials |
Linda M. Quinn |
|
6 |
| SUGI |
1994 |
SAS Software Techniques in Longitudinal Studies of Health Outcomes and Costs |
Julia Hecht, Jenifer Ehreth, Mary Durham, David Grembowski, Joseph Picciano |
source |
6 |
| SUGI |
1994 |
Using SAS/FSP to Develop an On-line Randomization System for Multicenter Clinical Trials |
Margaret Lee, Dorothea Collins |
source |
6 |
| WUSS |
1993 |
Random Sampling Without Replacement |
Hong Zhou, Patrick Romano |
source |
2 |
| SEUGI |
1993 |
Support of Statistical Consulting Using SAS Software |
Hans-Peter Altenburg |
source |
11 |
| SUGI |
1993 |
Administering a Large, Long-Term Clinical Trial Requiring a Hierarchical Database Using the SAS System, Release 6.07 |
Mitchell Snyder, Mark Goldberg, Michal Benderly |
source |
6 |
| SUGI |
1993 |
Analysis of Split-Plot Experiments Using SAS Software |
Stephen P. Jones, Monica Y. Chi |
source |
6 |
| SUGI |
1992 |
A SAS Program to Create Output Files Used for a Randomization Code Distribution Procedure |
Joseph M. O'Connor, Ute E. Schwiderski, Joseph J. Andary |
source |
5 |
| SUGI |
1992 |
A SAS Window Application for Generating Follow-up Clinic Schedules and Monitoring Accrual in a VA Cooperative Study |
Joan Derrico |
source |
6 |
| SUGI |
1992 |
Blocked Randomized Assignment of Treatments to Patients in Clinical Trials |
Maria A. Deloria, George F. Reed |
source |
6 |
| SUGI |
1992 |
Essential SAS Software for Engineers |
William D. Kahn, Diccon R. E. Bancroft |
source |
10 |
| SUGI |
1992 |
Use of SAS/AF and SAS/FSP Software to Integrate a Payment System for Patient Information in a Large Multi-Center Clinical Trial |
Dorothea Collins, Margaret Lee |
source |
6 |
| SUGI |
1991 |
Experiment Design in Engineering Design and Development |
Douglas C. Montgomery |
source |
10 |
| SUGI |
1991 |
The ETRANK Procedure: Procedures for Analyzing Incomplete Repeated Measures Trials with Treatment Related Withdrawals |
Richard Entsuah, Edmond Williams |
source |
7 |
| SUGI |
1989 |
A Robust Code for Producing Stratified, Blocked Randomizations Utilizing VMS' Macro Facilities and the SET Statement with the POINT Option |
David W. Main |
source |
4 |
| SUGI |
1989 |
A SAS/IML Program for Randomization Analysis of Dose Response Curves |
Dean E. Nelson |
source |
4 |
| SUGI |
1989 |
Field Reliability Assessment Using the Proportional Hazards Model |
Stephen Freitas, Raymond V. Spring |
source |
5 |
| SUGI |
1988 |
CADAE: Computer-assisted Design and Analysis of Response Surface Experiments |
Mark J. Levine |
source |
4 |
| SUGI |
1988 |
SPAM: Spatial Autocorrelation Modeling |
Andrew J. R. Gillespie |
source |
5 |
| SUGI |
1986 |
Using SAS Software in the Design and Analysis of Two-Level Fractional Factorial Experiments |
Joanne R. Wendelberger |
source |
6 |
| SUGI |
1985 |
A Monte Carlo Comparison of Extended Mantel-Haenszel Procedures |
Daniel W. Griffin |
source |
6 |
| SUGI |
1984 |
On Generating Statistics, Formatting Results and Efficiency |
Ingrid A. Amara, Gary G. Koch |
source |
6 |
| SUGI |
1984 |
SEQURAN-An Interactive Sequential Randomization System for Clinical Trials |
Estelle M. Fondy, Jeannette Y. Lee |
source |
6 |
| SUGI |
1983 |
Overview of Categorical Data Analysis Methods |
Ingrid A. Amara, Susan Atkinson, Gary G. Koch, William M. Stanish |
source |
10 |
| SUGI |
1983 |
Randomization Tests |
Robert M. Hamer |
source |
9 |
| SUGI |
1983 |
Stratified Randomization Using SAS |
Joanne DiPietro, Sampson Tu |
source |
|
| SUGI |
1981 |
PROC RANDOMTEST: A SAS Procedure Performing Randomization Tests |
Robert M. Hamer |
source |
6 |
| SUGI |
1980 |
A Macro for Multivariate Randomization Analyses of Stratified Sample Data |
Ingrid A. Amara, Gary G. Koch |
source |
11 |
| SUGI |
1979 |
Randomization Schedules via SAS |
John L. Stedl |
source |
3 |